论文信息 - From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes

From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes

The National Cancer Institute Initiative in Chemical Genetics is designed to encourage the development of small molecular probes. The probes are useful for activating or inactivating protein functions, thereby providing resources that help discern the functions of gene products in normal and disease cells, as well as in tissues. This initiative includes “ChemBank,” a suite of informatics tools and databases aimed at promoting the development and use of chemical genetics by scientists worldwide. The information generated with such tools should provide a critical link from genomic discovery to drug development.

R. Strausberg | S. Schreiber

[1] S. Haggarty,et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. , 1999, Science.

[2] S. Schreiber,et al. Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[3] R. Strausberg,et al. Genome and genetic resources from the Cancer Genome Anatomy Project. , 2001, Human molecular genetics.

[4] P. Clemons,et al. A one-bead, one-stock solution approach to chemical genetics: part 2. , 2001, Chemistry & biology.

[5] John A. Tallarico,et al. A one-bead, one-stock solution approach to chemical genetics: part 1. , 2001, Chemistry & biology.

[6] T. Jacks,et al. Cancer Modeling in the Modern Era Progress and Challenges , 2002, Cell.

[7] T. Giordano,et al. RNAi: gene-silencing in therapeutic intervention. , 2002, Drug discovery today.

[8] Timothy J Mitchison,et al. Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II Inhibitor , 2003, Science.

[9] Stuart L. Schreiber,et al. The small-molecule approach to biology , 2003 .